Cargando…

How clinicians make decisions about CTOs in ACT: a qualitative study

BACKGROUND: The first 12 Norwegian assertive community treatment (ACT) teams were piloted from 2009 to 2011. Of the 338 patients included during the teams’ first year of operation, 38% were subject to community treatment orders (CTOs). In Norway as in many other Western countries, the use of CTOs is...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuen, Hanne Kilen, Landheim, Anne, Rugkåsa, Jorun, Wynn, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151000/
https://www.ncbi.nlm.nih.gov/pubmed/30258490
http://dx.doi.org/10.1186/s13033-018-0230-2
_version_ 1783357082410418176
author Stuen, Hanne Kilen
Landheim, Anne
Rugkåsa, Jorun
Wynn, Rolf
author_facet Stuen, Hanne Kilen
Landheim, Anne
Rugkåsa, Jorun
Wynn, Rolf
author_sort Stuen, Hanne Kilen
collection PubMed
description BACKGROUND: The first 12 Norwegian assertive community treatment (ACT) teams were piloted from 2009 to 2011. Of the 338 patients included during the teams’ first year of operation, 38% were subject to community treatment orders (CTOs). In Norway as in many other Western countries, the use of CTOs is relatively high despite lack of robust evidence for their effectiveness. The purpose of the present study was to explore how responsible clinicians reason and make decisions about the continued use of CTOs, recall to hospital and the discontinuation of CTOs within an ACT setting. METHODS: Semi-structured interviews with eight responsible clinicians combined with patient case files and observations of treatment planning meetings. The data were analysed using a modified grounded theory approach. RESULTS: The participants emphasized that being part of a multidisciplinary team with shared caseload responsibility that provides intensive services over long periods of time allowed for more nuanced assessments and more flexible treatment solutions on CTOs. The treatment criterion was typically used to justify the need for CTO. There was substantial variation in the responsible clinicians’ legal interpretation of dangerousness, and some clinicians applied the dangerousness criterion more than others. CONCLUSIONS: According to the clinicians, many patients subject to CTOs were referred from hospitals and high security facilities, and decisions regarding the continuation of CTOs typically involved multiple and interacting risk factors. While patients’ need for treatment was most often applied to justify the need for CTOs, in some cases the use of CTOs was described as a tool to contain dangerousness and prevent harm.
format Online
Article
Text
id pubmed-6151000
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61510002018-09-26 How clinicians make decisions about CTOs in ACT: a qualitative study Stuen, Hanne Kilen Landheim, Anne Rugkåsa, Jorun Wynn, Rolf Int J Ment Health Syst Research BACKGROUND: The first 12 Norwegian assertive community treatment (ACT) teams were piloted from 2009 to 2011. Of the 338 patients included during the teams’ first year of operation, 38% were subject to community treatment orders (CTOs). In Norway as in many other Western countries, the use of CTOs is relatively high despite lack of robust evidence for their effectiveness. The purpose of the present study was to explore how responsible clinicians reason and make decisions about the continued use of CTOs, recall to hospital and the discontinuation of CTOs within an ACT setting. METHODS: Semi-structured interviews with eight responsible clinicians combined with patient case files and observations of treatment planning meetings. The data were analysed using a modified grounded theory approach. RESULTS: The participants emphasized that being part of a multidisciplinary team with shared caseload responsibility that provides intensive services over long periods of time allowed for more nuanced assessments and more flexible treatment solutions on CTOs. The treatment criterion was typically used to justify the need for CTO. There was substantial variation in the responsible clinicians’ legal interpretation of dangerousness, and some clinicians applied the dangerousness criterion more than others. CONCLUSIONS: According to the clinicians, many patients subject to CTOs were referred from hospitals and high security facilities, and decisions regarding the continuation of CTOs typically involved multiple and interacting risk factors. While patients’ need for treatment was most often applied to justify the need for CTOs, in some cases the use of CTOs was described as a tool to contain dangerousness and prevent harm. BioMed Central 2018-09-22 /pmc/articles/PMC6151000/ /pubmed/30258490 http://dx.doi.org/10.1186/s13033-018-0230-2 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Stuen, Hanne Kilen
Landheim, Anne
Rugkåsa, Jorun
Wynn, Rolf
How clinicians make decisions about CTOs in ACT: a qualitative study
title How clinicians make decisions about CTOs in ACT: a qualitative study
title_full How clinicians make decisions about CTOs in ACT: a qualitative study
title_fullStr How clinicians make decisions about CTOs in ACT: a qualitative study
title_full_unstemmed How clinicians make decisions about CTOs in ACT: a qualitative study
title_short How clinicians make decisions about CTOs in ACT: a qualitative study
title_sort how clinicians make decisions about ctos in act: a qualitative study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151000/
https://www.ncbi.nlm.nih.gov/pubmed/30258490
http://dx.doi.org/10.1186/s13033-018-0230-2
work_keys_str_mv AT stuenhannekilen howcliniciansmakedecisionsaboutctosinactaqualitativestudy
AT landheimanne howcliniciansmakedecisionsaboutctosinactaqualitativestudy
AT rugkasajorun howcliniciansmakedecisionsaboutctosinactaqualitativestudy
AT wynnrolf howcliniciansmakedecisionsaboutctosinactaqualitativestudy